To further explore our findings in a clinically relevant setting, we analyzed the hLcn-2-dependent target genes SLC7A11, GCLM, and GLS at mRNA level in either tumor tissue or adjacent healthy tissue of 32 patients diagnosed with clear cell RCC (ccRCC). This evidence concerns the gene GCLM and nonpapillary renal cell carcinoma.